Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Spokane. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Spokane at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This is a Phase 1 and Phase 2 study to determine the safety profile, RDR and/or MTD, DLT, PK/PD, and preliminary antitumor activity of INV-9956 in adult patients with advanced mCRPC.
Sponsor: Shenzhen Ionova Life Sciences Co., Ltd.
Check if you qualify for this prostate cancer clinical trial in Spokane, WA
If you're searching for prostate cancer treatment options in Spokane, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Spokane research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.